{
 "PrintNo":"A8292","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-06-13T10:16:45.3488Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2019-06-13","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":612,"Name":"Aravella Simotas","Short":"SIMOTAS"}],
 "Title":"Relates to capping the amount paid for prescription insulin by an insured",
 "Summary":"Caps the amount paid by an insured for a 30 day supply of prescription insulin at one hundred dollars.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to limiting co-payments for insulin",
 "SameAsPrintNo":"S6263-2019"
}